$LEXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LEXICON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in LEXICON PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | M | 0.00 | 10,638 | 0 | 151,397 | 140.8 K to 151.4 K (+7.56 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | M | 0.00 | 10,638 | 0 | 151,397 | 140.8 K to 151.4 K (+7.56 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Buy | M | 0.00 | 10,638 | 0 | 27,720 | 17.1 K to 27.7 K (+62.28 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Buy | M | 0.00 | 10,638 | 0 | 27,720 | 17.1 K to 27.7 K (+62.28 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 10,638 | 0 | 327,521 | 316.9 K to 327.5 K (+3.36 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Buy | M | 0.00 | 10,638 | 0 | 66,291 | 55.7 K to 66.3 K (+19.11 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 10,638 | 0 | 327,521 | 316.9 K to 327.5 K (+3.36 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Buy | M | 0.00 | 10,638 | 0 | 66,291 | 55.7 K to 66.3 K (+19.11 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Buy | M | 0.00 | 10,638 | 0 | 27,006 | 16.4 K to 27 K (+64.99 %) |
Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 3.31 | 12,000 | 39,720 | 50,980 | |
Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 6.93 | 12,000 | 83,100 | 71,766 | 83.8 K to 71.8 K (-14.33 %) |
Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 3.31 | 12,000 | 39,720 | 83,766 | 71.8 K to 83.8 K (+16.72 %) |
Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 6.90 | 10,912 | 75,340 | 71,766 | 82.7 K to 71.8 K (-13.20 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 30,467 | 0 | 60,933 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 25,290 | 0 | 25,290 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 9,555 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,797 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 7.19 | 26,584 | 191,139 | 157,020 | 183.6 K to 157 K (-14.48 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 30,467 | 0 | 183,604 | 153.1 K to 183.6 K (+19.90 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 25,290 | 0 | 153,137 | 127.8 K to 153.1 K (+19.78 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 9,555 | 0 | 127,847 | 118.3 K to 127.8 K (+8.08 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,797 | 0 | 118,292 | 115.5 K to 118.3 K (+2.42 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 28,690 | 0 | 57,380 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 26,600 | 0 | 26,600 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,727 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 7.19 | 16,560 | 119,066 | 120,791 | 137.4 K to 120.8 K (-12.06 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 28,690 | 0 | 137,351 | 108.7 K to 137.4 K (+26.40 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 26,600 | 0 | 108,661 | 82.1 K to 108.7 K (+32.41 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,727 | 0 | 82,061 | 72.3 K to 82.1 K (+13.45 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 72,334 | 69.3 K to 72.3 K (+4.31 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 23,300 | 0 | 46,600 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 22,374 | 0 | 22,373 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 8,297 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 2,497 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Payment of Exercise | F | 7.19 | 20,413 | 146,769 | 140,695 | 161.1 K to 140.7 K (-12.67 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 23,300 | 0 | 161,108 | 137.8 K to 161.1 K (+16.91 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 22,374 | 0 | 137,808 | 115.4 K to 137.8 K (+19.38 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 8,297 | 0 | 115,434 | 107.1 K to 115.4 K (+7.74 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 2,497 | 0 | 107,137 | 104.6 K to 107.1 K (+2.39 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 21,030 | 0 | 42,060 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 11,100 | 0 | 11,100 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 5,118 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 1,517 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Payment of Exercise | F | 7.19 | 14,860 | 106,843 | 73,637 | 88.5 K to 73.6 K (-16.79 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 21,030 | 0 | 88,497 | 67.5 K to 88.5 K (+31.17 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 11,100 | 0 | 67,467 | 56.4 K to 67.5 K (+19.69 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 5,118 | 0 | 56,367 | 51.2 K to 56.4 K (+9.99 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 1,517 | 0 | 51,249 | 49.7 K to 51.2 K (+3.05 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 84,630 | 0 | 169,260 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 79,380 | 0 | 79,380 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 23,513 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 5,362 | 0 | 0 | |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 7.19 | 55,038 | 395,723 | 436,713 | 491.8 K to 436.7 K (-11.19 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 84,630 | 0 | 491,751 | 407.1 K to 491.8 K (+20.79 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 79,380 | 0 | 407,121 | 327.7 K to 407.1 K (+24.22 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 23,513 | 0 | 327,741 | 304.2 K to 327.7 K (+7.73 %) |
Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 5,362 | 0 | 304,228 | 298.9 K to 304.2 K (+1.79 %) |
Jan 05 2021 | LEXG | LEXICON PHARMACEUT ... | Invus C.V. | Director | Sell | J | 0.00 | 4,321,214 | 0 | 0 | 4.3 M to 0 (-100.00 %) |
Dec 17 2020 | LEXG | LEXICON PHARMACEUT ... | Artal International S.C.A. | Director | Buy | P | 3.20 | 10,937,500 | 35,000,000 | 32,259,461 | 21.3 M to 32.3 M (+51.30 %) |
Dec 17 2020 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 3.20 | 10,937,500 | 35,000,000 | 32,259,461 | 21.3 M to 32.3 M (+51.30 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Buy | M | 0.00 | 3,466 | 0 | 16,368 | 12.9 K to 16.4 K (+26.86 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | M | 0.00 | 3,466 | 0 | 140,759 | 137.3 K to 140.8 K (+2.52 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Buy | M | 0.00 | 3,466 | 0 | 16,368 | 12.9 K to 16.4 K (+26.86 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Buy | M | 0.00 | 3,466 | 0 | 17,082 | 13.6 K to 17.1 K (+25.46 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Buy | M | 0.00 | 3,466 | 0 | 16,368 | 12.9 K to 16.4 K (+26.86 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 3,466 | 0 | 316,883 | 313.4 K to 316.9 K (+1.11 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Buy | M | 0.00 | 3,466 | 0 | 55,653 | 52.2 K to 55.7 K (+6.64 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Buy | M | 0.00 | 3,466 | 0 | 16,368 | 12.9 K to 16.4 K (+26.86 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 1.96 | 9,651 | 18,916 | 115,495 | 125.1 K to 115.5 K (-7.71 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Grant | A | 0.00 | 26,525 | 0 | 125,146 | 98.6 K to 125.1 K (+26.90 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 1.96 | 4,844 | 9,494 | 69,344 | 74.2 K to 69.3 K (-6.53 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Grant | A | 0.00 | 19,893 | 0 | 74,188 | 54.3 K to 74.2 K (+36.64 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.96 | 3,997 | 7,834 | 65,127 | 69.1 K to 65.1 K (-5.78 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Grant | A | 0.00 | 13,262 | 0 | 69,124 | 55.9 K to 69.1 K (+23.74 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 1.96 | 6,813 | 13,353 | 55,584 | 62.4 K to 55.6 K (-10.92 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Grant | A | 0.00 | 19,893 | 0 | 62,397 | 42.5 K to 62.4 K (+46.80 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Payment of Exercise | F | 1.96 | 6,813 | 13,353 | 104,640 | 111.5 K to 104.6 K (-6.11 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Grant | A | 0.00 | 19,893 | 0 | 111,453 | 91.6 K to 111.5 K (+21.73 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Payment of Exercise | F | 1.96 | 6,398 | 12,540 | 49,732 | 56.1 K to 49.7 K (-11.40 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Grant | A | 0.00 | 19,893 | 0 | 56,130 | 36.2 K to 56.1 K (+54.90 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 1.96 | 6,813 | 13,353 | 85,719 | 92.5 K to 85.7 K (-7.36 %) |
Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Grant | A | 0.00 | 19,893 | 0 | 92,532 | 72.6 K to 92.5 K (+27.39 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 26,600 | 0 | 53,200 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,726 | 0 | 9,727 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 2,990 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 26,600 | 0 | 54,295 | 27.7 K to 54.3 K (+96.05 %) |